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Background:  High plasma aldosterone levels at presentation for STEMI are associated with poor outcome. We hypothesized that early aldosterone 
receptor blockade at admission may improve outcome.
Methods:  163 consecutive patients admitted for primary PCI for STEMI were treated by 200 mg IV potassium canrenonate at presentation, 
followed by soludactone 25 mg daily during the hospital stay. Such patients were compared to 262 randomly selected controls matched on the 
admission GRACE score’s deciles and symptom-onset to presentation time. The pre-specified outcome of the study was the composite of death, 
resuscitated cardiac arrest (RCA) and ventricular tachycardia (VT). The outcome was assessed at hospital discharge and at 6 months follow-up
Results:  Aldosterone blockade significantly reduced the rates of the composite endpoint both at discharge and at follow-up. Such therapy was 
also associated with a significant reduction of rates of resuscitated RCA and VT and a trend towards less ventricular fibrillation (VF) and high degree 
atrioventricular block (AVB). After further adjustment on ejection fraction, reperfusion success, admission or peak plasma potassium levels, the 
results remained unchanged.
Conclusions:  Early aldosterone blockade on admission for primary PCI improves hospital outcome by reducing potentially lethal arrhythmias. Such 
effects are independent of patients’ risk level at presentation, ejection fraction and plasma potassium levels, and persist at 6 months follow-up.
Association between aldosterone blockade and outcome
In-hospital OR
Death/RCA/VT 0.23 [0.1-0.51]
Death 1.9 [0.49-7.4]
ACR 0.27 [0.07-0.096
VF 0.29 [0.08-1.04]
VT 0.22 [0.09-0.52]
AVB 0.31 [0.07-1.4]
6 Month HR
Death/RCA/VT 0.95 [0.92-0.99]
Death 0.90 [0.78-1.02]
